ABT Abbott Laboratories

P/E 26.36
Forward P/E 17.18
Price/Sales 3.632
Beta 0.62
Div Yield 0.0262%
Market Cap --

Company Analysis

Latest News

Abbott Secures FDA Approval for Volt PFA System to Treat Atrial Fibrillation

On December 22, Abbott Laboratories received FDA approval for its Volt™ Pulsed Field Ablation (PFA) System, designed to treat atrial fibrillation (AFib). This...